Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Cited by (1,093)

Items 901–1,000 of 1,093

1. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/ SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary
   Thomas G. Brott, Jonathan L. Halperin, Suhny Abbara, J. Michael Bacharach, John Dean Barr, Ruth L. Bush, Christopher U. Cates, Mark A. Creager, Susan A. Fowler, Gary H. Friday et al. · 2011 · Vascular Medicine
2. Cost-Effectiveness of Screening and Optimal Management for Diabetes, Hypertension, and Chronic Kidney Disease: A Modeled Analysis
   Kirsten Howard, Sarah White, Glenn P. Salkeld, Stephen Peter McDonald, Jonathan C. Craig, Steven James Chadban, Alan Cass · 2009 · Value in Health
3. The impact of premorbid diabetic status on the relationship between the three domains of glycemic control and mortality in critically ill patients
   James Stephen Krinsley, Geert Meyfroidt, Greet Van den Berghe, Mori Egi, Rinaldo Bellomo · 2012 · Current Opinion in Clinical Nutrition & Metabolic Care
4. The Role of Mitochondria in Diabetic Kidney Disease
   Stein Ivar Hallan, Kumar Sharma · 2016 · Current Diabetes Reports
5. Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial
   Anderson, Robert J., Bahn, Gideon D., Moritz, Thomas E., Kaufman, Derrick, Abraira, Carlos, Duckworth, William, for the VADT Study Group · 2011 · Diabetes Care
6. Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes
   Ueki, Kohjiro, Sasako, Takayoshi, Okazaki, Yukiko, Miyake, Kana, Nangaku, Masaomi, Ohashi, Yasuo, Noda, Mitsuhiko, Kadowaki, Takashi · 2021 · Kidney International
7. Tratamiento de la diabetes tipo 2 en el paciente anciano
   Ricardo Gómez‐Huelgas, Javier Díez‐Espino, Francesç Formiga, Javier Lafita Tejedor, Leocadio Rodríguez‐Mañas, Enrique González-Sarmiento, Edelmiro Luis Menéndez Torre, Javier Sangrós · 2012 · Medicina Clínica
8. Cardiovascular effects of the DPP-4 inhibitors
   Tessey Jose, Silvio E. Inzucchi · 2012 · Diabetes and Vascular Disease Research
9. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways
   Nikhil Sahajpal, Rajesh Kumar Goel, Alka Chaubey, Rohan Aurora, Subheet Kumar Jain · 2018 · Current Protein and Peptide Science
10. Cardiomyopathy Associated with Diabetes: The Central Role of the Cardiomyocyte
    Tiziana Filardi, Barbara Ghinassi, Angela Di Baldassarre, Gaetano Tanzilli, Susanna Morano, Andrea Lenzi, Stefania Basili, Clara Crescioli · 2019 · International Journal of Molecular Sciences
11. Renal Function Trajectory Is More Important than Chronic Kidney Disease Stage for Managing Patients with Chronic Kidney Disease
    Steven Jay Rosansky · 2012 · American Journal of Nephrology
12. Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy
    Heling Wen, Zhongshu Liang, Rui Zhang, Kan Yang · 2013 · Cardiovascular Diabetology
13. Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)
    for the VADT Study Group, Agrawal, Lily, Azad, Nasrin, Bahn, Gideon D., Ge, Ling, Reaven, Peter D., Hayward, Rodney A., Reda, Domenic J., Emanuele, Nicholas V. · 2018 · Diabetologia
14. HbA1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study
    Pazin-Filho, A., Kottgen, A., Bertoni, A. G., Russell, S. D., Selvin, E., Rosamond, W. D., Coresh, J. · 2008 · Diabetologia
15. Cardiac implications of hypoglycaemia in patients with diabetes – a systematic review
    M Hanefeld, E D Dütting, Peter Bramlage · 2013 · Cardiovascular Diabetology
16. Assessment of flow dynamics in retinal and choroidal microcirculation
    Xin Wei, Praveen Kumar Balne, Kenith E. Meissner, Veluchamy A. Barathi, Leopold F. Schmetterer, Rupesh V. Agrawal · 2018 · Survey of Ophthalmology
17. Safety and Effectiveness of Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3a/3b CKD
    Andrew S. Allegretti, Wenbin Zhang, Wenjiong Zhou, Tara K. Thurber, Scott P. Rigby, Cynthia Bowman-Stroud, Carlos Trescolí, Pierre Sérusclat, Mason Wright Freeman, Yuan‐Di C. Halvorsen · 2019 · American Journal of Kidney Diseases
18. Diabetic Kidney Disease: Diagnosis, Treatment, and Prevention.
    Kathryn L McGrath, Rina Edi · 2019 · PubMed
19. American Geriatrics Society Identifies Another Five Things That Healthcare Providers and Patients Should Question
    AGS Choosing Wisely Workgroup · 2014 · Journal of the American Geriatrics Society
20. Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association
    Robert A. Gabbay, Debbie Kendall, Christine Beebe, John K. Cuddeback, Todd M. Hobbs, Naeem D. Khan, Sandra Leal, Eden M Miller, Lucia M. Novak, Swapnil N. Rajpathak et al. · 2020 · Clinical Diabetes
21. Hormones and Aging: An Endocrine Society Scientific Statement
    Anne Rentoumis Cappola, Richard Joseph Auchus, Ghada El‐Hajj Fuleihan, David J. Handelsman, Rita Rastogi Kalyani, Michael R. McClung, Cynthia A. Stuenkel, Michael O. Thorner, Joseph George Verbalis · 2023 · The Journal of Clinical Endocrinology & Metabolism
22. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study
    Connie Mah Trinacty, Alyce Sophia Adams, Stephen B. Soumerai, Fang Zhang, James B. Meigs, John D. Piette, Dennis Ross‐Degnan · 2009 · BMC Health Services Research
23. Concomitant Diabetes Mellitus and Heart Failure
    Alessandra Dei, Gregg C. Fonarow, Mihai Gheorghiade, Javed Butler · 2014 · Current Problems in Cardiology
24. DPP-4 inhibitors: What may be the clinical differentiators?
    John E. Gerich · 2010 · Diabetes Research and Clinical Practice
25. Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: Comparison by prevalent cardiovascular disease status
    Nathan D. Wong, Christopher Patao, Kalina Wong, Shaista Malik, Stanley S. Franklin, Uchenna H. Iloeje · 2013 · Diabetes and Vascular Disease Research
26. Sodium‐glucose co‐transporter type‐2 inhibitors: pharmacology and peri‐operative considerations
    David A. Milder, Tamara Y. Milder, Peter C. A. Kam · 2018 · Anaesthesia
27. Management of diabesity: Current concepts
    Maria Michaelidou, Joseph M Pappachan, Mohammad Sadiq Jeeyavudeen · 2023 · World Journal of Diabetes
28. Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting
    Seyed Ebrahim Kassaian, Hamidreza Goodarzynejad, Mohammad Ali Boroumand, Mojtaba Salarifar, Farzad Masoudkabir, Mohammad Reza Mohajeri‐Tehrani, Hamidreza Pourhosseini, Saeed Sadeghian, Narges Ramezanpour, Mohammad Alidoosti et al. · 2012 · Cardiovascular Diabetology
29. Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus
    Stephan Matthaei, R. Bierwirth, Andreas Fritsche, Baptist Gallwitz, Hans‐Ulrich Häring, Hans‐Georg Joost, Monika Kellerer, Ch. Kloos, T. Kunt, Michael Albrecht Nauck et al. · 2009 · Experimental and Clinical Endocrinology & Diabetes
30. Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study
    Saremi, Aramesh, Howell, Scott, Schwenke, Dawn C., Bahn, Gideon, Beisswenger, Paul J., Reaven, Peter D., for the VADT Investigators · 2017 · Diabetes Care
31. Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority study
    Nobuya Inagaki, Hitoshi Onouchi, Hideaki Maezawa, Shingo Kuroda, Kohei Kaku · 2015 · The Lancet Diabetes & Endocrinology
32. Treatment approach and HbA1c control among US adults with type 2 diabetes: NHANES 1999–2004
    Allison Hedley Dodd, Margaret S. Colby, Kristina Secnik Boye, Cheryl Fahlman, Sunny Wonsun Kim, RONETTE R. BRIEFEL · 2009 · Current Medical Research and Opinion
33. Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus
    Wensheng Yue, Kui Kai Lau, Chung‐Wah Siu, Mei Wang, Guo-Hui Yan, Kai‐Hang Yiu, Hung‐Fat Tse · 2011 · Cardiovascular Diabetology
34. Evaluating the Effect of a Diabetes Health Coach in Individuals with Type 2 Diabetes
    Diana Sherifali, Virginia Viscardi, Johnny-Wei Bai, R. Muhammad Usman Ali · 2016 · Canadian Journal of Diabetes
35. Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
    Lavanya Athithan, Gaurav Singh Gulsin, Gerry Patrick McCann, Eylem Levelt · 2019 · World Journal of Diabetes
36. Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes
    David E. Kloecker, Melanie Jane Davies, Kamlesh Khunti, Francesco Zaccardi · 2020 · Annals of Internal Medicine
37. Mechanisms of diabetic kidney disease and established and emerging treatments
    Victor Martinez Leon, Rachel Hilburg, Katalin Suszták · 2025 · Nature Reviews Endocrinology
38. Coming full circle in diabetes mellitus: from complications to initiation
    Brooke E. Harcourt, Sally A. Penfold, Josephine Maree Forbes · 2013 · Nature Reviews Endocrinology
39. Evidence-Informed Guidelines for Treating Frail Older Adults With Type 2 Diabetes: From the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) Program
    Laurie Herzig Mallery, Tom Ransom, Brian Steeves, Brenda Cook, Peggy Dunbar, Paige A. Moorhouse · 2013 · Journal of the American Medical Directors Association
40. Induction of Vascular Insulin Resistance and Endothelin-1 Expression and Acceleration of Atherosclerosis by the Overexpression of Protein Kinase C-β Isoform in the Endothelium
    Qian Li, Kyoungmin Park, Chen-Zhong Li, Christian Rask‐Madsen, Akira Mima, Weier Qi, Koji Mizutani, Paul Lee Huang, George Liang King · 2013 · Circulation Research
41. Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study
    Wilfried Dinh, Mark Lankisch, Werner Nickl, Daniel Scheyer, Thomas Scheffold, Frank Kramer, Thomas Krahn, Rolf Michael Klein, Michael Coll Barroso, Reiner Füth · 2010 · Cardiovascular Diabetology
42. Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data?
    L. Gregg, S. Hedayati · 2018 · American Journal of Kidney Diseases
43. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: A move towards a unified glucose tetrad concept
    Monnier, Louis, Colette, Claude, Owens, David R. · 2009 · Diabetes/Metabolism Research and Reviews
44. Glycemic Management in ESRD and Earlier Stages of CKD
    Mark E. Williams, Rajesh Garg · 2014 · American Journal of Kidney Diseases
45. Neurodegeneration and Neuroprotection in Diabetic Retinopathy
    Mohammad Shamsul Ola, Mohd Imtiaz Nawaz, Haseeb Ahmad Khan, Abdullah Salih Alhomida · 2013 · International Journal of Molecular Sciences
46. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes Mellitus
    Marian Sue Kirkman, Hussain Mahmud, Mary T. Korytkowski · 2018 · Endocrinology and Metabolism Clinics of North America
47. Diabetic heart disease: A clinical update
    Jake Rajbhandari, Cornelius James Fernandez, Mayuri Agarwal, Beverly Xin Yi Yeap, Joseph M Pappachan · 2021 · World Journal of Diabetes
48. Susceptibility of LDL and its subfractions to glycation
    Handrean Soran, Paul N. Durrington · 2011 · Current Opinion in Lipidology
49. Insulin Use in Elderly Adults: Risk of Hypoglycemia and Strategies for Care
    Robert J. Ligthelm, Marcel Kaiser, Jiten P Vora, Jean‐François Yale · 2012 · Journal of the American Geriatrics Society
50. A call to incorporate the prevention and treatment of geriatric disorders in the management of diabetes in the elderly
    Ulrich M. Vischer, Bernard Bauduceau, Isabelle Bourdel‐Marchasson, J F Blicklé, Thierry Constans, Anne Fagot‐Campagna, Edgar Kaloustian, V. Lassman-Vague, P. Lecomte, D. Simon et al. · 2009 · Diabetes & Metabolism
51. Risk of Mortality and Hospitalization After Post-Pancreatitis Diabetes Mellitus vs Type 2 Diabetes Mellitus: A Population-Based Matched Cohort Study
    Jaelim Cho, Robert K.R. Scragg, Maxim S. Petrov · 2019 · The American Journal of Gastroenterology
52. Self-Monitoring of Blood Glucose in Type 2 Diabetes: Recent Studies
    Schnell, Oliver, Alawi, Hasan, Battelino, Tadej, Ceriello, Antonio, Diem, Peter, Felton, Anne-Marie, Grzeszczak, Wladyslaw, Harno, Kari, Kempler, Peter, Satman, Ilhan et al. · 2013 · Journal of Diabetes Science and Technology
53. Diabetes and Cardiovascular Disease: an Update
    Almourani, Rajaa, Chinnakotla, Bhavana, Patel, Richa, Kurukulasuriya, L. Romayne, Sowers, James · 2019 · Current Diabetes Reports
54. Evidence‐based diabetes care for older people with Type 2 diabetes: a critical review
    Alan J. Sinclair, Ahmed H. Abdelhafiz, Angus Forbes, Medha N. Munshi · 2018 · Diabetic Medicine
55. Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial
    Geert Jan Biessels, C. Verhagen, Jolien Janssen, Esther van den Berg, Bernard Zinman, Julio Rosenstock, Jyothis Thomas George, Anna Passera, Sven Schnaidt, Odd Erik Johansen · 2019 · Diabetes Care
56. Atherogenic dyslipidemia and diabetic nephropathy
    Giuseppina Tiziana Russo, Pamela Angela Piscitelli, Annalisa Giandalia, Francesca Chiara Viazzi, Roberto Pontremoli, Paola Fioretto, Salvatore De Cosmo · 2020 · Journal of Nephrology
57. Postprandial and Basal Glucose in Type 2 Diabetes: Assessment and Respective Impacts
    Louis Monnier, C Colette, David R. Owens · 2011 · Diabetes Technology & Therapeutics
58. The Mitochondria in Diabetic Heart Failure: From Pathogenesis to Therapeutic Promise
    Joel D. Schilling · 2015 · Antioxidants and Redox Signaling
59. Metabolic Memory and Chronic Diabetes Complications: Potential Role for Epigenetic Mechanisms
    Robert V. A. Intine, Michael P. Sarras · 2012 · Current Diabetes Reports
60. Diabetic Kidney Disease: Act Now or Pay Later
    Robert C. Atkins, Paul Zimmet · 2008 · Pediatric Nephrology
61. The glycemic triumvirate and diabetic complications: Is the whole greater than the sum of its component parts?
    L. Monnier, C Colette, David Owens · 2011 · Diabetes Research and Clinical Practice
62. Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin’s glucose-lowering effects
    Cheol Hwangbo, Jingxia Wu, Irinna Papangeli, Takaomi Adachi, Bikram Sharma, Saejeong Park, Lina Zhao, Hyekyung Ju, Gwang‐woong Go, Guoliang Cui et al. · 2017 · Science Translational Medicine
63. Management of diabetes in older adults
    Giorgio Sesti, Raffaele Antonelli Incalzi, Enzo Bonora, Agostino Consoli, Andrea Giaccari, Stefania Maggi, Giuseppe Paolisso, Francesco Purrello, Gianluigi Vendemiale, Nicola Ferrara · 2017 · Nutrition Metabolism and Cardiovascular Diseases
64. Association Between Severe Hypoglycemia, Adverse Macrovascular Events, and Inflammation in the Edinburgh Type 2 Diabetes Study
    Bedenis, Rachel, Price, Anna H., Robertson, Christine M., Morling, Jo R., Frier, Brian M., Strachan, Mark W.J., Price, Jackie F. · 2014 · Diabetes Care
65. Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseases
    Kirti S. Bhatt, Mitsuo V. Kato, Rama D Natarajan · 2015 · American Journal of Physiology-Renal Physiology
66. Trends in Antidiabetic Prescription Patterns in Japan From 2005 to 2011
    Takahide Kohro, Tsutomu Yamazaki, Hiroki Sato, Kenji Harada, Kazuhiko Ohe, Issei Komuro, Ryozo Nagai · 2013 · International Heart Journal
67. Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes
    Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito · 2018 · Journal of Endocrinological Investigation
68. Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes
    Merlin C. Thomas, Mark Woodward, Bruce Charles Neal, Qiang Li, R. J. Pickering, Michel Marre, Bryan Williams, Vlado Perkovic, Mark Emmanuel Cooper, Sophia Zoungas et al. · 2015 · Diabetes Care
69. Diabetes and obesity: therapeutic targeting and risk reduction – a complex interplay
    Kevin Dean Niswender · 2009 · Diabetes Obesity and Metabolism
70. Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study
    P. G. H. Janssen, Kees J. Gorter, Ronald P. Stolk, Guy E.H.M. Rutten · 2008 · British Journal of General Practice
71. Pharmacologic Prevention of Microvascular and Macrovascular Complications in Diabetes Mellitus
    Nikhil Tandon, Mohammed Kumail Ali, K.M. Venkat Narayan · 2012 · American Journal of Cardiovascular Drugs
72. The influence of physical activity on vascular complications and mortality in patients with type 2 diabetes mellitus
    Blomster, J. I., Chow, C. K., Zoungas, S., Woodward, M., Patel, A., Poulter, N. R., Marre, M., Harrap, S., Chalmers, J., Hillis, G. S. · 2013 · Diabetes, Obesity and Metabolism
73. Microalbuminuria: A parameter that has changed diabetes care
    Hans‐Henrik Parving, Frederik Persson, Peter R Rossing · 2014 · Diabetes Research and Clinical Practice
74. Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin—based therapies
    Kiwon Ban, Sonya Hui, Daniel J. Drucker, Mansoor Husain · 2009 · Journal of the American Society of Hypertension
75. High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization
    Shipra Arya, Zachary O. Binney, Anjali Khakharia, Chandler A. Long, Luke Packard Brewster, Peter W.F. Wilson, William D. Jordan, Yazan M. Duwayri · 2017 · Journal of Vascular Surgery
76. The Impact of Weight Gain on Motivation, Compliance, and Metabolic Control in Patients with Type 2 Diabetes Mellitus
    Xavier Pi-Sunyer · 2009 · Postgraduate Medicine
77. Prevalence and risk factors of neuropathic pain in survivors of myocardial infarction with pre‐diabetes and diabetes. The KORA Myocardial Infarction Registry
    Dan Ziegler, Wolfgang Rathmann, Christa Meisinger, Thorsten Dickhaus, Andreas Mielck, For the KORA Study Group · 2008 · European Journal of Pain
78. Lipotoxicity in Diabetic Nephropathy
    Mariana Murea, Barry I. Freedman, John S. Parks, Peter A. Antinozzi, Steven C. Elbein, Lijun Ma · 2010 · Clinical Journal of the American Society of Nephrology
79. Glycaemic control is improved by 7 days of aerobic exercise training in patients with type 2 diabetes
    Catherine R. Mikus, Douglas J. Oberlin, Jessica L. Libla, L. J. Boyle, John P. Thyfault · 2012 · Diabetologia
80. The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?
    Karen E. Porter, Kirsten Riches‐Suman · 2013 · Clinical Science
81. Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk
    Francesco Giorgino, Jiten P Vora, Peter Fenici, Anna Solini · 2020 · Cardiovascular Diabetology
82. Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what?
    Douglas R. Farrell, Joseph A. Vassalotti · 2024 · BMC Nephrology
83. Efficacy, safety and dose–response relationship of teneligliptin, a dipeptidyl peptidase‐4 inhibitor, in Japanese patients with type 2 diabetes mellitus
    Takashi Kadowaki, K. Kondo · 2013 · Diabetes Obesity and Metabolism
84. Blood Pressure Variables and Cardiovascular Risk
    André Pascal Kengne, Sébastien Czernichow, Rachel Huxley, Diederick E. Grobbee, Mark Woodward, Bruce Charles Neal, Sophia Zoungas, Mark Cooper, Paul Glasziou, Pavel Hamet et al. · 2009 · Hypertension
85. Current management of diabetes mellitus and future directions in care
    Sudesna Chatterjee, Melanie Jane Davies · 2015 · Postgraduate Medical Journal
86. Diabetes and Risk of Arterial Stiffness: A Mendelian Randomization Analysis
    Min Xu, Ya Fang Huang, Lan Xie, Kui Peng, Lin Ding, Lin Lin, Wang Po, Mingli Hao, Yuhong Chen, Yimin Sun et al. · 2016 · Diabetes
87. Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials
    Morten Hansen, David Peick Sonne, Stine Ulrik Mikkelsen, Lise Lotte Gluud, Tina Vilsbøll, Filip Krag Knop · 2017 · Journal of Diabetes and its Complications
88. Diabetes and Peripheral Vascular Disease
    Fabienne Huysman, Chantal Mathieu · 2009 · Acta chirurgica Belgica
89. Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction
    Marianne Benn, Anne Tybjærg‐Hansen, Mark I. McCarthy, Gorm Boje Jensen, Peer Grande, Børge Grønne Nordestgaard · 2012 · Journal of the American College of Cardiology
90. Novel oral glucose‐lowering drugs are associated with lower risk of all‐cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes
    Thomas Nyström, Johan Bodegård, David Nathanson, Marcus Thuresson, Anna Norhammar, Jan W. Eriksson · 2017 · Diabetes Obesity and Metabolism
91. Management of Type 2 Diabetes in Developing Countries: Balancing Optimal Glycaemic Control and Outcomes with Affordability and Accessibility to Treatment
    Viswanathan Mohan, Kamlesh Khunti, Siew Pheng Chan, Fadlo Fraige Filho, Nam Quang Tran, Kaushik L. Ramaiya, Shashank Joshi, Ambrish Mithal, Maïmouna Ndour Mbaye, Nemencio Almare Nicodemus et al. · 2019 · Diabetes Therapy
92. Chronic stable coronary artery disease: drugs vs. revascularization
    Maarten L. Simoons, Stephan Windecker · 2010 · European Heart Journal
93. Pharmacist Assisted Medication Program Enhancing the Regulation of Diabetes (PAMPERED) study
    Michelle L. Jacobs, Pamela S. Sherry, Leigh M. Taylor, Mary G. Amato, Gary R. Tataronis, Gary W. Cushing · 2012 · Journal of the American Pharmacists Association
94. Fixed‐dose single tablet antidiabetic combinations
    Clifford J. Bailey, Caroline Day · 2009 · Diabetes Obesity and Metabolism
95. From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitus
    Bays, Harold · 2009 · Current Medical Research and Opinion
96. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: Randomised clinical trial (MDI Liraglutide trial)
    Lind, Marcus, Hirsch, Irl B, Tuomilehto, Jaakko, Dahlqvist, Sofia, Ahrén, Bo, Torffvit, Ole, Attvall, Stig, Ekelund, Magnus, Filipsson, Karin, Tengmark, Bengt-Olov et al. · 2015 · BMJ
97. Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes
    Paneni, Francesco, Lüscher, Thomas F. · 2017 · The American Journal of Cardiology
98. Diabetes mellitus: new challenges and innovative therapies
    C. Sena, Carla F. Bento, P. Pereira, R. Seiça · 2010 · The EPMA Journal
99. Target for Glycemic Control
    Monnier, Louis, Colette, Claude · 2009 · Diabetes Care
100. Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors
     Lin, Donna Shu-Han, Lee, Jen-Kuang, Chen, Wen-Jone · 2021 · Diabetologia